Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arye Blachar

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 27, 2016
PANCREATIC INCIDENTALOMA: DIFFERENTIATING NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS FROM INTRAPANCREATIC ACCESSORY SPLEENEster Osher, Erez Scapa, Joseph Klausner, et al.
The Israel Medical Association Journal : IMAJ|March 29, 2005
Donor recruitment and selection for adult-to-adult living donor liver transplantation in urgent and elective circumstancesMenahem Ben-Haim, Michal Carmiel, Nir Lubezky, et al.
Radiology|May 9, 2002
Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteriaArye Blachar, Michael P Federle, James V Ferris, et al.
Oncogene|May 7, 2021
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cellsShiran Shapira, Eynat Finkelshtein, Dina Kazanov, et al.
Journal of Clinical & Translational Endocrinology|September 4, 2023
Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entityEsther Osher, Ravit Geva, Ido Wolf, et al.
Biomedicines|February 25, 2023
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine TumorsEsther Osher, Eiman Shalabna, Joseph M Klausner, et al.
The Israel Medical Association Journal : IMAJ|May 11, 2010
First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention centerBen Boursi, Hanan Guzner-Gur, Yaquv Mashich, et al.
Radiology|July 2, 2003
Prevalence effect in a laboratory environmentDavid Gur, Howard E Rockette, Derek R Armfield, et al.
European Journal of Internal Medicine|January 15, 2013
One stop screening for multiple cancers: the experience of an integrated cancer prevention centerTal Sella, Ben Boursi, Amira Gat-Charlap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Data From a One-Stop-Shop Comprehensive Cancer Screening CenterEzra Bernstein, Shahar Lev-Ari, Shiran Shapira, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 27, 2016
PANCREATIC INCIDENTALOMA: DIFFERENTIATING NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS FROM INTRAPANCREATIC ACCESSORY SPLEENEster Osher, Erez Scapa, Joseph Klausner, et al.
The Israel Medical Association Journal : IMAJ|March 29, 2005
Donor recruitment and selection for adult-to-adult living donor liver transplantation in urgent and elective circumstancesMenahem Ben-Haim, Michal Carmiel, Nir Lubezky, et al.
Radiology|May 9, 2002
Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteriaArye Blachar, Michael P Federle, James V Ferris, et al.
Oncogene|May 7, 2021
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cellsShiran Shapira, Eynat Finkelshtein, Dina Kazanov, et al.
Journal of Clinical & Translational Endocrinology|September 4, 2023
Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entityEsther Osher, Ravit Geva, Ido Wolf, et al.
Biomedicines|February 25, 2023
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine TumorsEsther Osher, Eiman Shalabna, Joseph M Klausner, et al.
The Israel Medical Association Journal : IMAJ|May 11, 2010
First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention centerBen Boursi, Hanan Guzner-Gur, Yaquv Mashich, et al.
Radiology|July 2, 2003
Prevalence effect in a laboratory environmentDavid Gur, Howard E Rockette, Derek R Armfield, et al.
European Journal of Internal Medicine|January 15, 2013
One stop screening for multiple cancers: the experience of an integrated cancer prevention centerTal Sella, Ben Boursi, Amira Gat-Charlap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Data From a One-Stop-Shop Comprehensive Cancer Screening CenterEzra Bernstein, Shahar Lev-Ari, Shiran Shapira, et al.
Pageof 5